Qifu Li
Johnson & Johnson (United States)(US)Sun Yat-sen University(CN)Yunnan University(CN)Fudan University(CN)Second People's Hospital of Yunnan Province(CN)Zhongshan Hospital(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)First Affiliated Hospital of Chongqing Medical University(CN)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)First Affiliated Hospital of Zhengzhou University(CN)Yunnan University of Traditional Chinese Medicine(CN)Jisc(GB)Chongqing Medical University(CN)
Publications by Year
Research Areas
Hormonal Regulation and Hypertension, Adrenal and Paraganglionic Tumors, Adrenal Hormones and Disorders, Diabetes Treatment and Management, Diabetes Management and Research
Most-Cited Works
- → Standards of medical care for type 2 diabetes in China 2019(2019)752 cited
- → Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice(2018)382 cited
- → Standards of care for type 2 diabetes in China(2016)320 cited
- → Primary Aldosteronism in Patients in China With Recently Detected Hypertension(2020)219 cited
- → Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity(2014)194 cited
- → AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity(2016)170 cited